Compositions and methods for treatment of chronic fatigue
AssigneeK-PAX Pharmaceuticals, Inc.
InventorJon D. Kaiser
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions and methods for the treatment of chronic fatigue in human patients comprising a central nervous system (CNS) stimulant in a daily low-dosage amount in combination with therapeutically effective daily amounts of micronutrients, comprising acetyl L-carnitine, L-tyrosine, N-acetyl cysteine, and alpha-lipoic acid. The CNS and micronutrient components may be in an oral dosage composition containing a low dosage amount of CNS stimulant such as about 2.5 mg methylphenidate HCl together with about 60-250 mg acetyl L-carnitine, 50-200 mg L-tyrosine, 60-250 mg N-acetyl cysteine, and 25-100 mg alpha-lipoic acid.
Claims13
A method for treating chronic fatigue in a human patient comprising:
- administering a daily dosage of about 2.5 to 40 mg methylphenidate;
- and
- administering daily about 100 to 2000 mg acetyl L-carnitine,
- about 100 to 2000 mg L-tyrosine,
- about 100 to 2000 mg N-acetyl cysteine, and
- about 50 to 1000 mg alpha lipoic acid.
Dependencies are inferred from the claim text.